Japanese drugmaker Takeda has suffered a blow to its late-stage pipeline, after the FDA rejected its marketing application for TAK-721, a drug candidate that is trying to be the first approved therapy ...

Takeda Pharma less impacted by tariff, yen headwinds than others: CEO Got a confidential news tip? We want to hear from you. Sign up for free newsletters and get more CNBC delivered to your inbox Get ...

TAK is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of TAK shares has increased $0.04 since the market last closed. This is a 0.22% ...

Takeda has said it intends to move quickly ahead with regulatory filings for oveporexton, its orexin agonist for sleep disorder narcolepsy, after a clean sweep of positive efficacy data in two phase 3 ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

VANGUARD Intl Eqy. INDEX Fd.S-Vanguard FTSE All-World ex-US Index Fd. 123.37k Jan 31, 2026 0.00% 2,277,483 ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Table tennis champion Fan Zhendong (right) plays local player Wong Chun-ting with giant paddles in a fun match at the opening of Kai Tak Sports Park in Hong Kong on Saturday. [Photo/Xinhua] Hong Kong ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following business ...